vs
CENTURY ALUMINUM CO（CENX）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是CENTURY ALUMINUM CO的1.2倍（$772.1M vs $633.7M），Revvity净利率更高（12.7% vs 0.3%，领先12.5%），Revvity同比增速更快（5.9% vs 0.4%），Revvity自由现金流更多（$161.8M vs $67.7M），过去两年CENTURY ALUMINUM CO的营收复合增速更高（13.8% vs 9.0%）
世纪铝业是总部位于美国的原铝生产商，在美国肯塔基州、南卡罗来纳州及冰岛均设有铝生产工厂，是美国规模最大的原铝生产商，在纳斯达克上市，总部坐落于芝加哥南瓦克尔大道1号。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
CENX vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.2倍
$633.7M
营收增速更快
RVTY
高出5.4%
0.4%
净利率更高
RVTY
高出12.5%
0.3%
自由现金流更多
RVTY
多$94.1M
$67.7M
两年增速更快
CENX
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $633.7M | $772.1M |
| 净利润 | $1.8M | $98.4M |
| 毛利率 | 13.0% | — |
| 营业利润率 | 5.2% | 14.5% |
| 净利率 | 0.3% | 12.7% |
| 营收同比 | 0.4% | 5.9% |
| 净利润同比 | -96.0% | 3.9% |
| 每股收益（稀释后） | $0.03 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CENXRVTY
| Q4 25 | $633.7M | $772.1M | ||
| Q3 25 | $632.2M | $698.9M | ||
| Q2 25 | $628.1M | $720.3M | ||
| Q1 25 | $633.9M | $664.8M | ||
| Q4 24 | $630.9M | $729.4M | ||
| Q3 24 | $539.1M | $684.0M | ||
| Q2 24 | $560.8M | $691.7M | ||
| Q1 24 | $489.5M | $649.9M |
净利润CENXRVTY
| Q4 25 | $1.8M | $98.4M | ||
| Q3 25 | $14.9M | $46.7M | ||
| Q2 25 | $-4.6M | $53.9M | ||
| Q1 25 | $29.7M | $42.2M | ||
| Q4 24 | $45.2M | $94.6M | ||
| Q3 24 | $47.3M | $94.4M | ||
| Q2 24 | $-2.5M | $55.4M | ||
| Q1 24 | $246.8M | $26.0M |
毛利率CENXRVTY
| Q4 25 | 13.0% | — | ||
| Q3 25 | 12.2% | 53.6% | ||
| Q2 25 | 5.8% | 54.5% | ||
| Q1 25 | 9.6% | 56.5% | ||
| Q4 24 | 10.5% | — | ||
| Q3 24 | 15.2% | 56.3% | ||
| Q2 24 | 3.6% | 55.7% | ||
| Q1 24 | 3.4% | 54.6% |
营业利润率CENXRVTY
| Q4 25 | 5.2% | 14.5% | ||
| Q3 25 | 9.2% | 11.7% | ||
| Q2 25 | 3.3% | 12.6% | ||
| Q1 25 | 7.3% | 10.9% | ||
| Q4 24 | 7.8% | 16.3% | ||
| Q3 24 | 11.8% | 14.3% | ||
| Q2 24 | 1.1% | 12.4% | ||
| Q1 24 | 0.4% | 6.8% |
净利率CENXRVTY
| Q4 25 | 0.3% | 12.7% | ||
| Q3 25 | 2.4% | 6.7% | ||
| Q2 25 | -0.7% | 7.5% | ||
| Q1 25 | 4.7% | 6.4% | ||
| Q4 24 | 7.2% | 13.0% | ||
| Q3 24 | 8.8% | 13.8% | ||
| Q2 24 | -0.4% | 8.0% | ||
| Q1 24 | 50.4% | 4.0% |
每股收益（稀释后）CENXRVTY
| Q4 25 | $0.03 | $0.86 | ||
| Q3 25 | $0.15 | $0.40 | ||
| Q2 25 | $-0.05 | $0.46 | ||
| Q1 25 | $0.29 | $0.35 | ||
| Q4 24 | $0.58 | $0.77 | ||
| Q3 24 | $0.46 | $0.77 | ||
| Q2 24 | $-0.03 | $0.45 | ||
| Q1 24 | $2.26 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $134.2M | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $805.6M | $7.3B |
| 总资产 | $2.3B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CENXRVTY
| Q4 25 | $134.2M | $919.9M | ||
| Q3 25 | $151.4M | $931.4M | ||
| Q2 25 | $40.7M | $991.8M | ||
| Q1 25 | $44.9M | $1.1B | ||
| Q4 24 | $32.9M | $1.2B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | $41.3M | $2.0B | ||
| Q1 24 | $93.5M | $1.7B |
股东权益CENXRVTY
| Q4 25 | $805.6M | $7.3B | ||
| Q3 25 | $741.8M | $7.4B | ||
| Q2 25 | $724.4M | $7.6B | ||
| Q1 25 | $726.3M | $7.6B | ||
| Q4 24 | $694.4M | $7.7B | ||
| Q3 24 | $628.5M | $7.9B | ||
| Q2 24 | $601.5M | $7.9B | ||
| Q1 24 | $601.5M | $7.8B |
总资产CENXRVTY
| Q4 25 | $2.3B | $12.2B | ||
| Q3 25 | $2.1B | $12.1B | ||
| Q2 25 | $1.9B | $12.4B | ||
| Q1 25 | $2.0B | $12.4B | ||
| Q4 24 | $1.9B | $12.4B | ||
| Q3 24 | $2.1B | $12.8B | ||
| Q2 24 | $1.8B | $13.4B | ||
| Q1 24 | $1.8B | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $102.8M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $67.7M | $161.8M |
| 自由现金流率自由现金流/营收 | 10.7% | 21.0% |
| 资本支出强度资本支出/营收 | 5.5% | 2.6% |
| 现金转化率经营现金流/净利润 | 57.11× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $84.8M | $509.4M |
8季度趋势，按日历期对齐
经营现金流CENXRVTY
| Q4 25 | $102.8M | $182.0M | ||
| Q3 25 | $2.0M | $138.5M | ||
| Q2 25 | $7.9M | $134.3M | ||
| Q1 25 | $72.3M | $128.2M | ||
| Q4 24 | $-41.4M | $174.2M | ||
| Q3 24 | $20.1M | $147.9M | ||
| Q2 24 | $11.5M | $158.6M | ||
| Q1 24 | $-14.8M | $147.6M |
自由现金流CENXRVTY
| Q4 25 | $67.7M | $161.8M | ||
| Q3 25 | $-18.1M | $120.0M | ||
| Q2 25 | $-15.9M | $115.5M | ||
| Q1 25 | $51.1M | $112.2M | ||
| Q4 24 | $-54.6M | $149.8M | ||
| Q3 24 | $-2.4M | $125.6M | ||
| Q2 24 | $-5.4M | $136.6M | ||
| Q1 24 | $-44.5M | $129.7M |
自由现金流率CENXRVTY
| Q4 25 | 10.7% | 21.0% | ||
| Q3 25 | -2.9% | 17.2% | ||
| Q2 25 | -2.5% | 16.0% | ||
| Q1 25 | 8.1% | 16.9% | ||
| Q4 24 | -8.7% | 20.5% | ||
| Q3 24 | -0.4% | 18.4% | ||
| Q2 24 | -1.0% | 19.7% | ||
| Q1 24 | -9.1% | 20.0% |
资本支出强度CENXRVTY
| Q4 25 | 5.5% | 2.6% | ||
| Q3 25 | 3.2% | 2.6% | ||
| Q2 25 | 3.8% | 2.6% | ||
| Q1 25 | 3.3% | 2.4% | ||
| Q4 24 | 2.1% | 3.4% | ||
| Q3 24 | 4.2% | 3.3% | ||
| Q2 24 | 3.0% | 3.2% | ||
| Q1 24 | 6.1% | 2.7% |
现金转化率CENXRVTY
| Q4 25 | 57.11× | 1.85× | ||
| Q3 25 | 0.13× | 2.97× | ||
| Q2 25 | — | 2.49× | ||
| Q1 25 | 2.43× | 3.03× | ||
| Q4 24 | -0.92× | 1.84× | ||
| Q3 24 | 0.42× | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | -0.06× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CENX
| Aluminum | $566.3M | 89% |
| Alumina | $67.4M | 11% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
